Literature DB >> 14969821

The mRNA profile of genes in betel quid chewing oral cancer patients.

Wan-Chi Tsai1, Sen-Tien Tsai, Jenq-Yuh Ko, Ying-Tai Jin, Ching Li, Wenya Huang, Kung-Chia Young, Ming-Der Lai, Hsiao-Sheng Liu, Li-Wha Wu.   

Abstract

Oral cancer is one of the most common types of human cancer in the world. Although the risk factors for oral cancer are well-recognized in different countries, the molecular mechanism responsible for this malignancy remains elusive particularly in the countries where betel quid chewing is prevalent. The cDNA microarray analysis was used to analyse the mRNA expression patterns of 1177 genes in ten oral cancer patients with betel quid chewing history. Eighty-four genes involving cell adhesion, cell shape, growth, apoptosis, angiogenesis, metastasis, and metabolism were deregulated. Although the expression profile of these genes was shared by certain clinical patients, there was no significant association of the expression profile with clinical staging. Functional implication of four validated genes including caspase-1, STAT-1, COX-2 and pleiotrophin was discussed. This study provides pilot data for understanding the pathogenesis of oral cancer in countries like Taiwan where betel quid chewing is prevalent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14969821     DOI: 10.1016/j.oraloncology.2003.09.015

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  7 in total

Review 1.  Glycogen synthase kinase 3 beta: can it be a target for oral cancer.

Authors:  Rajakishore Mishra
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

2.  MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma.

Authors:  Li-Hsin Chen; Kun-Ling Tsai; Yi-Wei Chen; Cheng-Chia Yu; Kuo-Wei Chang; Shi-Hwa Chiou; Hung-Hai Ku; Pen-Yuan Chu; Ling-Ming Tseng; Pin-I Huang; Wen-Liang Lo
Journal:  J Oncol       Date:  2011-02-15       Impact factor: 4.375

3.  DNA microarrays in herbal drug research.

Authors:  Preeti Chavan; Kalpana Joshi; Bhushan Patwardhan
Journal:  Evid Based Complement Alternat Med       Date:  2006-10-27       Impact factor: 2.629

Review 4.  Gene expression profiling for the purposes of biomarker discovery in oral potentially malignant lesions: a systematic review.

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Clin Med Insights Oncol       Date:  2013-10-31

5.  Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse.

Authors:  Benjamin Lallemant; Alexandre Evrard; Christophe Combescure; Heliette Chapuis; Guillaume Chambon; Caroline Raynal; Christophe Reynaud; Omar Sabra; Dominique Joubert; Frédéric Hollande; Jean-Gabriel Lallemant; Serge Lumbroso; Jean-Paul Brouillet
Journal:  BMC Cancer       Date:  2009-10-18       Impact factor: 4.430

6.  Searching for molecular markers in head and neck squamous cell carcinomas (HNSCC) by statistical and bioinformatic analysis of larynx-derived SAGE libraries.

Authors:  Nelson J F Silveira; Leonardo Varuzza; Ariane Machado-Lima; Marcelo S Lauretto; Daniel G Pinheiro; Rodrigo V Rodrigues; Patrícia Severino; Francisco G Nobrega; Wilson A Silva; Carlos A de B Pereira; Eloiza H Tajara
Journal:  BMC Med Genomics       Date:  2008-11-11       Impact factor: 3.063

7.  Cyclooxygenase-2-1195G>A Polymorphism and Head and Neck Squamous Cell Carcinoma Susceptibility: A Meta-Analysis of 1564 Cases and 2346 Controls.

Authors:  Dong-Lai Deng; Ling-Yun Xia; Bing-Yang He; Jing-Mei Guo; Cui Huang; Xian-Tao Zeng
Journal:  Med Sci Monit       Date:  2015-11-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.